Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial

• Harald Prüss ,

  Contributed equally to this work with: Harald Prüss, Berit Rosche, Aaron B. Sullivan

  * E-mail: jan.schwab@charite.de (JMS); harald.pruess@charite.de (HP)

  Affiliation Department of Neurology & Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany

  ⨯
• Berit Rosche ,

  Contributed equally to this work with: Harald Prüss, Berit Rosche, Aaron B. Sullivan

  Affiliation Department of Neurology & Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany

  ⨯
• Aaron B. Sullivan ,

  Contributed equally to this work with: Harald Prüss, Berit Rosche, Aaron B. Sullivan

  Affiliation Vision Science Program, School of Optometry, University of California, Berkeley, California, United States of America

  ⨯
• Benedikt Brommer,

  Affiliation Department of Neurology & Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany

  ⨯
• Oliver Wengert,

  Affiliation Department of Neurology & Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany

  ⨯
• Karsten Gronert ,

  ¶These authors also contributed equally to this work.

  Affiliation Vision Science Program, School of Optometry, University of California, Berkeley, California, United States of America

  ⨯
• Jan M. Schwab

  * E-mail: jan.schwab@charite.de (JMS); harald.pruess@charite.de (HP)

  ¶These authors also contributed equally to this work.

  Affiliation Department of Neurology & Experimental Neurology, Charité University Medicine Berlin, Berlin, Germany

  ⨯